Paul Tudor Jones’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Paul Tudor Jones’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.9M	Sell	94,300 -238,200	-72%	-$32.2M	0.02%	618
2026 Q1	$42.5M	Sell	332,500 -52,500	-14%	-$6.55M	0.08%	185
2025 Q4	$46.9M	Buy	385,000 +62,500	+19%	+$7.17M	0.09%	177
2025 Q3	$32.3M	Buy	322,500 +90,000	+39%	+$8.11M	0.06%	274
2025 Q2	$19.3M	Buy	+232,500	New	+$18.5M	0.04%	345
2024 Q4	–	Sell	-50,000	Closed	-$4.94M	–	3579
2024 Q3	$4.94M	Buy	50,000 +25,000	+100%	+$2.46M	0.02%	716
2024 Q2	$2.32M	Buy	+25,000	New	+$2.24M	0.01%	988

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Paul Tudor Jones's XBI Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 502,000 shares worth $79.4M. The stake represents 0.11% of the portfolio and ranks #119 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in XBI as recently as Q2 2025.

Paul Tudor Jones first reported a position in XBI in Q4 2016 and has held it in 11 quarters since. 931 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Paul Tudor Jones held 502,000 shares of State Street SPDR S&P Biotech ETF worth $79.4M as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Paul Tudor Jones position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.11% of Paul Tudor Jones's portfolio in Q2 2026, its #119 holding.
Paul Tudor Jones first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 11 quarters since.
931 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.